Education
About Us
Working with TipRanks
Follow Us
Tanvex Biopharma (TANVF)
:TANVF
TANVF Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
---
TANVF FAQ
What was Tanvex Biopharma ’s price range in the past 12 months?
Currently, no data Available
What is Tanvex Biopharma ’s market cap?
Currently, no data Available
When is Tanvex Biopharma ’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Tanvex Biopharma ’s earnings last quarter?
Tanvex Biopharma released its earnings results on Mar 14, 2025. The company reported -$0.052 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.052.
Is Tanvex Biopharma overvalued?
According to Wall Street analysts Tanvex Biopharma ’s price is currently Undervalued.
Does Tanvex Biopharma pay dividends?
Tanvex Biopharma does not currently pay dividends.
What is Tanvex Biopharma ’s EPS estimate?
Tanvex Biopharma ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Tanvex Biopharma have?
Currently, no data Available
What happened to Tanvex Biopharma ’s price movement after its last earnings report?
Tanvex Biopharma reported an EPS of -$0.052 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Tanvex Biopharma ?
Currently, no hedge funds are holding shares in TANVF
---
Company Description
Tanvex Biopharma
Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in research, development, manufacture, and sale of biosimilar products. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others.
---
ADMA Biologics
―
ANI Pharmaceuticals
―
Eagle Pharmaceuticals
―
Crinetics Pharmaceuticals
―
Regeneron
―
Incyte
―
---